Enfortumab Vedotin and Pembrolizumab as Monotherapies and Combination Treatment in Locally Advanced or Metastatic Urothelial Carcinoma : A Narrative Review
Date
2023-12-01
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Bantounou, M A, Plascevic, J, MacDonald, L, Wong, M C, O'Connell, N & Galley, H 2023, 'Enfortumab Vedotin and Pembrolizumab as Monotherapies and Combination Treatment in Locally Advanced or Metastatic Urothelial Carcinoma : A Narrative Review', Current Urology , vol. 17, no. 4, pp. 271-279. https://doi.org/10.1097/CU9.0000000000000204